Authors
Zaid H.
Klip A.
Conference
The American Diabetes Asossiation (ADA) 67th scientific Session
Proceeding Volume
56
Location
Chicago, IL, USA
Pages From

Abstract

Dietary glucose is mainly taken up by skeletal muscle, primarily through glucose transporter GLUT4. We recently identified a cohort of proteins that co-purify with GLUT4 upon immunoprecipitation and mass spectrometry analysis (J Proteome Res, 2006). Myc-tagged GLUT4 (GLUT4myc) stably expressed in L6 myotubes was immunoprecipitated from total cell lysates via the myc epitope. One attractive co-precipitating protein is glyceraldehyde-3-phosphate dehydrogenase (GAPDH), an enzyme involved not only in glycolytic ATP generation but also recently shown to interact with membranes and the cytoskeleton. Here, we applied in vitro pull-down assays using chimeric Glutathione S-Transferase (GST) fusion proteins linearly encompassing the cytosol-directed regions of GLUT4 or GLUT1 (N and C terminus and cytoplasmic loop), or the cytoplasmic loops alone, each bound to Sepharose beads. Commercial, purified human GAPDH, or endogenous GAPDH from L6 cell lysates bound to GST-GLUT4-cytosolic gt; GST-GLUT4-loop gt; GST-GLUTl-loop. GST alone did not pull down GAPDH. Addition of GLUT4 C-terminus peptide, but not cytoplasmic loop or N-terminal peptides, decreased GAPDH pull-down by cyto-GLUT4. These results suggest that GAPDH binds directly to GLUT4 cytosolic regions, and that the GLUT4 C-terminus contributes to such binding. Immuno-dot blot assay also showed that GAPDH binds to the purified GST-GLUTs constructs but not to GST alone. Seeking the physiological effect of the GAPDH-GLUT interaction, we knocked-down GAPDH via siRNA. A 60-70% reduction in GAPDH levels had no effect on glucose uptake or surface GLUT4 levels with or without insulin stimulation. Interestingly, however, the levels of Hexokinase-II coprecipitating with GLUT4myc from L6 cell lysates, increased upon GAPDH knock-down. These results indicate that GAPDH interacts directly with GLUT4 and that, this interaction might be part of a glycolytic metabolon, such that GAPDH may compete with Hexokinase-II. This project has the potential to reveal new mechanisms of regulation of glucose flux and utilization in muscle.